| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Usage # |
|---|
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-skin-functions-vs.json | Personal Functioning and Engagement Functions of Skin and Related Structures Value Set | trial-use | 3 | pc | 2026-03 | |
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-structures-voice-and-speech-vs.json | Personal Functioning and Engagement Structures Involved in Voice and Speech Value Set | trial-use | 3 | pc | 2026-03 | |
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-voice-and-speech-vs.json | Personal Functioning and Engagement Voice and Speech Functions Value Set | trial-use | 3 | pc | 2026-03 | |
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-products-and-technology-vs.json | Personal Functioning and Engagement Products and Technology Value Set | trial-use | 3 | pc | 2026-03 | |
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-goals-panel-vs.json | Personal Functioning and Engagement Goals Panel Value Set | trial-use | 3 | pc | 2026-03 | |
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-panel-vs.json | Personal Functioning and Engagement Panel Value Set | trial-use | 3 | pc | 2026-03 | |
| hl7.fhir.us.davinci-cdex | R4 | ValueSet/ValueSet-cdex-loinc-attachment-codes.json | CDex LOINC Attachment Codes Value Set | trial-use | 2 | claims | 2022-06 | 2 |
| hl7.fhir.us.davinci-pas | R4 | ValueSet/ValueSet-pas-loinc-attachment-codes.json | PAS LOINC Attachment Codes Value Set | trial-use | 4 | fm | 2022-06 | |
| hl7.fhir.us.carin-bb | R4 | ValueSet/ValueSet-C4BBProfessionalAndNonClinicianClaimSubType.json | C4BB Professional And Non Clinician Claim SubType Value Set | trial-use | 2 | fm | 2026-03 | |
| hl7.fhir.us.carin-bb | R4 | ValueSet/ValueSet-C4BBProfessionalAndNonClinicianClaimType.json | C4BB Professional And Non Clinician Claim Type Value Set | trial-use | 2 | fm | 2026-03 | 1 |
| signal.core.r4 | R4 | ValueSet/valueset-financial-resources-status-code.json | Financial Resource Status Codes | draft | 2 | fm | 2019-10 | |
| fhir.deep6.ai | R4 | ValueSet/ValueSet-deep-6-ai-documentreference-category.json | Deep 6 AI DocumentReference Category Value Set | active | | | 2023-12 | 1 |
| fhir.deep6.ai | R4 | ValueSet/ValueSet-deep-6-ai-location-type.json | Deep 6 AI Location Type Value Set | active | | | 2023-08 | 1 |
| fhir.deep6.ai | R4 | ValueSet/ValueSet-deep-6-ai-location-physical-type.json | Deep 6 AI Location Physical Type Value Set | active | | | 2023-11 | 1 |
| fhir.ph.core | R4 | ValueSet/ValueSet-drugs-vs.json | Drugs | draft | | | 2026-04 | 5 |
| hl7.fhir.us.qicore | R4 | ValueSet/ValueSet-qicore-medication-dose-type.json | QICore SNOMED CT Dosage Codes | trial-use | 4 | cqi | 2018-08 | |
| fhir.onc.us-quality-core | R4 | ValueSet/ValueSet-us-quality-core-medication-dose-type.json | USQualityCore SNOMED CT Dosage Codes | draft | | | 2026-03 | 1 |
| hl7.fhir.us.insurance-card | R4 | ValueSet/ValueSet-C4DICContactTypeVS.json | C4DIC Contact Type | trial-use | 2 | claims | 2026-03 | 1 |
| hl7.fhir.us.insurance-card | R4 | ValueSet/ValueSet-C4DICCopayTypeVS.json | C4DIC Copay Type | trial-use | 2 | claims | 2026-03 | 1 |
| hl7.fhir.us.insurance-card | R4 | ValueSet/ValueSet-C4DICCoverageClassVS.json | C4DIC Coverage Class | trial-use | 2 | claims | 2026-03 | 1 |
| signal.core.r4 | R4 | ValueSet/valueset-subscriber-relationship.json | SubscriberPolicyholder Relationship Codes | trial-use | 2 | fm | 2019-10 | |
| hl7.fhir.us.pacio-pfe | R4 | ValueSet/ValueSet-pfe-category-vs.json | Personal Functioning and Engagement Category Value Set | trial-use | 3 | pc | 2026-03 | 4 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/ValueSet-rtpbc-prescribable-product-code.json | RTPBC Prescribable Product Code Value Set | trial-use | 2 | phx | 2020-05 | 5 |
| signal.core.r4 | R4 | ValueSet/valueset-languages.json | Common Languages | draft | 5 | fm | 2016-08 | |
| signal.core.r4 | R4 | ValueSet/valueset-coverage-copay-type-code.json | Coverage Copay Type Codes | trial-use | 2 | fm | 2019-10 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.146.json | Buprenorphine | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.166.json | Codeine Schedule II and III | active | | | 2023-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.167.json | Alfentanil | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.168.json | Remifentanil | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.169.json | Sufentanil | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1125.1.json | Schedule IV Benzodiazepines | active | | | 2025-02 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.11.json | Oxycodone | active | | | 2023-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.12.json | Oxymorphone | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.70.json | Morphine | active | | | 2024-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.71.json | Methadone Medications | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.72.json | Meperidine | active | | | 2024-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.73.json | Levorphanol | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.74.json | Hydromorphone | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.75.json | Hydrocodone | active | | | 2025-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1002.76.json | Fentanyl | active | | | 2024-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1004.12.json | Butorphanol | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1004.15.json | Opium Combinations | active | | | 2024-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1004.16.json | Pentazocine | active | | | 2024-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1004.17.json | Tapentadol | active | | | 2021-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1004.18.json | Tramadol | active | | | 2024-02 | 1 |
| hl7.fhir.us.mihr | R4 | ValueSet/ValueSet-hypertensive-disorders-pregnancy-ICD.json | ValueSet – Hypertensive Disorders of Pregnancy ICD | draft | | | 2023-03 | 1 |
| hl7.fhir.us.mihr | R4 | ValueSet/ValueSet-hypertensive-disorders-pregnancy-SNOMED.json | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT | draft | | | 2023-03 | 1 |
| hl7.fhir.us.eltss | R4 | ValueSet/ValueSet-eltss-observation-code.json | Observation Code Value Set | informative | | hsswg | 2019-09 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.11.20.9.69.6.json | Planned or Completed moodCode | active | | | 2024-06 | |
| hl7.fhir.us.pacio-toc.r4b | R4B | ValueSet/ValueSet-toc-loinc-answered-by-LL5571-6-vs.json | Transitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Set | trial-use | 2 | pc | 2025-03 | 1 |
| hl7.fhir.us.pacio-toc | R4 | ValueSet/ValueSet-toc-del-loinc-vs.json | Transitions of Care DEL LOINC Terms Value Set | trial-use | 2 | pc | 2026-04 | 1 |
| hl7.fhir.us.pacio-toc.r4b | R4B | ValueSet/ValueSet-toc-del-loinc-answered-by-LL5571-6-vs.json | Transitions of Care LOINC Terms Included in the DEL Answered by LL5571-6 Answer List Value Set | trial-use | 2 | pc | 2025-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.28.json | Problem Type (LOINC) | active | | | 2023-07 | 3 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.11.20.9.39.json | Result Status | active | | | 2024-06 | 6 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.476.json | Allergy To Vaccine Component | active | | | 2023-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.2.json | InstructionActStatus | active | | | 2017-11 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.11.20.9.69.7.json | Obligation or Prohibition Instruction Type | active | | | 2017-11 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.58.json | Findings Related to Medication Management, Chronic Disease Present | active | | | 2023-12 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.59.json | Findings Related to Medication Management, Taking Medication for Chronic Disease | active | | | 2017-08 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1219.150.json | Fall or Fall Risk from Wheelchair or Scooter ICD10CM | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1219.147.json | Mobility Impairment or Fall From Chair ICD10CM | active | | | 2022-03 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1219.144.json | Bed Confinement Impairment | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.302.json | Test Cervical Excision Procedures | active | | | 2023-10 | |
| hl7.fhir.us.core | R4 | ValueSet/ValueSet-us-core-screening-assessment-observation-maximum-category.json | US Core Screening Assessment Observation Maximum Category | trial-use | 3 | cgp | 2024-11 | 2 |
| hl7.fhir.us.core | R4 | ValueSet/ValueSet-us-core-simple-observation-category.json | US Core Simple Observation Category | trial-use | 3 | cgp | 2024-11 | 5 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.11.20.9.87.json | Postpartum Status | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.190123.json | Diagnostic Mammography Study | active | | | 2018-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1902.json | Ultrasound of the Breast | active | | | 2019-01 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.190412.json | Screening Mammography and DBT Studies | active | | | 2018-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.4066.json | Diagnostic DBT Study | active | | | 2022-05 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.13883.3.3157.4067.json | MRI of the Breast | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.13883.3.3157.4068.json | MRI of the Breast | active | | | 2022-05 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.25.json | Detailed race including absence reasons. | active | | | 2025-04 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.6.json | Personal Health Goals LOINC | active | | | 2024-07 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.13.json | Healthcare Agent Powers or Limitations Indicator | active | | | 2024-11 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.208.json | Sexual Orientation | active | | | 2024-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.264.json | CDS Pregnancy | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.265.json | CDS Pregnancy Intensional | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.11.json | Cirrhosis ICD9CM | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.13.json | Cirrhosis SNOMEDCT | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.14.json | Cirrhosis | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.179.json | Abortion Medications | active | | | 2024-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.184.json | Letrozole (Aromatase inhibitor) | active | | | 2024-04 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.12.json | Negative | active | | | 2023-08 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1095.11.json | Nutrition Focused Physical Findings SNOMED CT | active | | | 2025-01 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.207.json | PharmacyEnvironmentsOfCare | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.205.json | PharmacyTypeOfProfession | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.181.json | PharmacyEncounterReason | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.197.json | PharmacyAllergies | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.198.json | PharmacyInterventions | active | | | 2024-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.200.json | PharmacyReasonsForInterventions | active | | | 2024-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.201.json | PharmacyInterventionStatus | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.202.json | PharmacyCareCoordination | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.203.json | PharmacyReferralsTo | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.204.json | PharmacyGoalStatusOutcome | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.208.json | PharmacyEncounterType | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.209.json | PharmacytEncounterClass | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.211.json | PharmacyAllergyIntoleranceType | active | | | 2018-09 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.212.json | PharmacyAllergyIntoleranceManifestation | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.213.json | PharmacyReasonForMedicationChange | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.214.json | PharmacyEducation | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.215.json | PharmacyEducationStatus | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.216.json | PharmacyReferralsFrom | active | | | 2022-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.7.json | Health Goals Grouping | active | | | 2022-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.177.json | Mifepristone | active | | | 2024-04 | 1 |
| hl7.fhir.us.core | R4 | ValueSet/ValueSet-us-core-screening-assessment-observation-category.json | US Core Screening Assessment Observation Category | trial-use | 3 | cgp | 2024-11 | 3 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1248.107.json | Mechanical Ventilation | active | | | 2022-05 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1248.109.json | aPTT Tests | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1248.106.json | Mechanical Ventilation | active | | | 2024-01 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.96.json | Dependence on dialysis | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.117.json | Syphilis Tests | active | | | 2023-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.1.11.20.2.9.json | Nutrition Recommendations | active | | | 2018-05 | 3 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.1.11.15913.json | EntityNameUse | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.365.json | Hospice Care Referral or Admission | active | | | 2025-05 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.2.json | Abdomen CT with contrast | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.21.json | Abdomen CT Without then With Contrast | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1.json | Abdomen CT without contrast | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1017.json | Adrenal Mass | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1020.json | Hematuria | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1021.json | Infections of Kidney | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1022.json | Jaundice | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1023.json | Liver Lesion (Mass or Neoplasm) | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1024.json | Malignant Neoplasm of Bladder | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1025.json | Malignant Neoplasm of Pancreas | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1026.json | Non Traumatic Aortic Disease | active | | | 2023-11 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1027.json | Pancreatic Disorder | active | | | 2025-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1028.json | Unspecified Disorder of Kidney and Ureter | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1805.json | MRI Lumbar Spine Procedures | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1802.json | Physical Therapy | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1812.json | Biomechanical Lesions (not Elsewhere Classified) | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1809.json | Other Deforming Dorsopathies | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1813.json | Dislocation or Sprain of those Joints and Ligaments Located in the Lumbar Spine or Pelvis | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1811.json | Other Dorsopathies | active | | | 2021-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1810.json | Spondylopathies | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.3157.1803.json | Chiropractic Evaluation | active | | | 2020-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.13883.3.3157.4069.json | Intraspinal Abscess | active | | | 2022-09 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.203.json | Intersex Surgery, All | active | | | 2024-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.192.json | Infertility, All | active | | | 2024-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.59.json | Medication Adherence SCT | active | | | 2024-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1240.8.json | Medication Adherence | active | | | 2023-10 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.599.json | PIM_Vitamin B12 Level_LOINC_CPT | active | | | 2023-09 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.1015.json | Substance Use | active | | | 2023-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.1016.json | Tobacco Use | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.1064.json | Marital or Spousal Status | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.1548.json | Cerebrovascular Disease Diagnosis SCT | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.1559.json | Metabolic Syndrome Diagnosis SCT | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.1585.json | Alcohol Use Related Questionnaire Panel Codes | active | | | 2024-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.1586.json | Functional Status Related Questionnaire Panel Codes | active | | | 2024-05 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.642.json | Intracranial Stenosis | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.742.json | Hypertriglyceridemia | active | | | 2024-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.757.json | Restless Leg Syndrome | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.807.json | Triiodothyronine in serum or plasma | active | | | 2024-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.910.json | Abdominal MRI | active | | | 2024-05 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1222.925.json | Foot MRI | active | | | 2024-07 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.166.json | Abortion, Surgical Management | active | | | 2024-04 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.167.json | Abortion, Surgical Management | active | | | 2024-04 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.168.json | Abortion, Surgical Management | active | | | 2024-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.180.json | Contraception, Surveillance | active | | | 2024-04 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.181.json | Contraception, Surveillance | active | | | 2024-04 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.182.json | Contraception, Surveillance | active | | | 2024-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.186.json | Infertility, Female | active | | | 2024-04 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.187.json | Infertility, Female | active | | | 2024-04 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1221.188.json | Infertility, Female | active | | | 2024-04 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.248.json | Suicide Attempt SNOMED CT | active | | | 2024-06 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.21.json | ALT | active | | | 2024-06 | |
| hl7.fhir.us.mihr | R4 | ValueSet/ValueSet-PregnancyNonLive.json | Pregnancy Non-Live | draft | | | 2023-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1219.193.json | Medication Supporting Immunosupressive Medication RxNorm | active | | | 2022-03 | |
| hl7.fhir.us.core | R4 | ValueSet/ValueSet-us-core-practitionerrole-specialty.json | US Core Practitioner Role Specialty Codes | trial-use | 3 | cgp | 2026-03 | 1 |
| hl7.fhir.us.core | R4 | ValueSet/ValueSet-us-core-location-type.json | US Core Location Type Codes | trial-use | 3 | cgp | 2026-03 | 1 |
| hl7.fhir.us.mihr | R4 | ValueSet/ValueSet-pregnancy.json | Pregnancy | draft | | | 2023-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1114.14.json | Medication drug class for allergen intolerance SCT | active | | | 2024-06 | 3 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1178.json | Pervasive Developmental Disorder | active | | | 2025-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.11.1180.json | Pervasive Developmental Disorder | active | | | 2025-03 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.105.12.1152.json | Pervasive Developmental Disorder | active | | | 2024-02 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.464.1003.196.11.1531.json | Potentially Harmful Benzodiazepines for Older Adults | active | | | 2025-01 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.264.json | Viral Hemorrhagic Fever (Disorders) (SNOMED) | active | | | 2024-01 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.265.json | Viral Hemorrhagic Fever (Disorders) (ICD10CM) | active | | | 2024-01 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.1151.json | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Antibody) | active | | | 2025-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.581.json | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid) | active | | | 2025-02 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.584.json | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody) | active | | | 2025-02 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.586.json | Viral Hemorrhagic Fever (Organism or Substance in Lab Results) | active | | | 2025-02 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.582.json | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Antigen) | active | | | 2025-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1146.585.json | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgM Antibody) | active | | | 2025-06 | |
| hl7.fhir.us.safr | R4 | ValueSet/ValueSet-us-safr-hrd-supply-days-example-codes.json | US SAFR Time Period Rantes Value Set | active | | | 2026-03 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.28.json | Urine drug screen for pain management | active | | | 2024-06 | |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.37.json | Care Plan Mood Codes | active | | | 2025-11 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.53.json | Sex | active | | | 2024-02 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.33.json | Disability Status Assertion | active | | | 2025-09 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.27.json | Care Team Member Function (SNOMEDCT) | active | | | 2023-07 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.21.json | Witness Categories | active | | | 2023-08 | 1 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.88.12.80.17.json | Medication Clinical General Drug | active | | | 2024-06 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113883.4.642.40.2.48.1.json | Detailed Ethnicity Including Absence Reasons | active | | | 2025-04 | 2 |
| us.nlm.vsac | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1213.111.json | Antidepressant Ingredients and Risk of GI Bleeding | active | | | 2023-12 | |
| hl7.fhir.us.ohsuhypertensionig | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.600.2012.json | Blood Pressure Measured | active | | | 2026-02 | |
| hl7.fhir.us.ohsuhypertensionig | R4 | ValueSet/ValueSet-2.16.840.1.113883.3.526.2.1045.json | Diastolic Blood Pressure | active | | | 2026-02 | |
| hl7.fhir.us.ohsuhypertensionig | R4 | ValueSet/ValueSet-2.16.840.1.113762.1.4.1104.2.json | Systolic blood pressure | active | | | 2026-02 | |
| hl7.fhir.us.vr-common-library | R4 | ValueSet/ValueSet-ValueSet-education-level-person-vr.json | Value Set - Education Level Person Vital Records | active | | pher | 2025-05 | 1 |
| hl7.fhir.us.vr-common-library | R4 | ValueSet/ValueSet-ValueSet-input-race-and-ethnicity-person-vr.json | Value Set - Input Race and Ethnicity Person Vital Records | active | | pher | 2025-05 | 1 |
| hl7.fhir.us.vr-common-library | R4 | ValueSet/ValueSet-ValueSet-father-relationship-vr.json | Value Set - Father Relationship Vital Records | active | | pher | 2025-05 | 1 |
| hl7.fhir.us.vr-common-library | R4 | ValueSet/ValueSet-ValueSet-mother-relationship-vr.json | Value Set - Mother Relationship Vital Records | active | | pher | 2025-05 | 1 |